Baird Reiterates an 'Outperform' on Human Genome Sciences (HGSI); Benlysta Off to a Solid Start, Q311 Estimates Look Safe
Go back to Baird Reiterates an 'Outperform' on Human Genome Sciences (HGSI); Benlysta Off to a Solid Start, Q311 Estimates Look Safe| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
